IBBQ:NASDAQInvesco Nasdaq Biotechnology ETF Analysis
Data as of 2026-08-22 - not real-time
$36.29
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Invesco Nasdaq Biotechnology ETF is bullish at $36.29, with short-term averages leading the long-term ones. Across the trailing 30 sessions it gained 9.7%. With RSI at 69.8 the momentum picture is approaching overbought, alongside a bullish MACD signal. Recent trading has carved out support near $31.75 and resistance around $36.84.
The 0.19% expense ratio is competitive for its category, and the fund manages $76.4M in assets.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 26.0%, a beta of 0.72 and a maximum drawdown of 8.5%, position sizing matters here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 4 out of 10.
The 0.19% expense ratio is competitive for its category, and the fund manages $76.4M in assets.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 26.0%, a beta of 0.72 and a maximum drawdown of 8.5%, position sizing matters here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 4 out of 10.
Top Market Events
Andy Gould, The Motley Fool Aug 1, 2026 0 Key Points - The Health Care Select Sector SPDR Fund XLV carries a lower...Vanguard's broad sector approach costs half as much and yields twice the dividend, while Invesco's biotech focus...Sara Appino, The Motley Fool Aug 13, 2026 0 Key Points - Invesco Nasdaq Biotechnology ETF has a lower expense ratio but...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 29.87
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 29.87
- MACD momentum is positive
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Low expense ratio of 0.19%
- Thin trading liquidity raises execution risk
- Short-term moving averages stacked above long-term ones
Key Metrics & Analysis
Fund Metrics
Expense Ratio0.19%
AUM$76.4M
Inception Date2021-06-11
Avg Daily Volume42,150
Premium/Discount0.00%
Tracking Error0.00%
Dividend Yield0.80%
Technical Analysis
TrendBullish
RSI69.8
Support$31.75
Resistance$36.84
MA 20$33.74
MA 50$32.68
MA 200$29.87
MACDBullish
VolumeIncreasing
Fear & Greed Index94.41
Risk Assessment
Beta0.72
Volatility25.96%
Sector RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.